Anesthetic

The term “anesthetic” does not refer to any unique molecular entity or therapeutic target, but instead encompasses a diverse group of compounds that induce reversible loss of sensation or consciousness, primarily for surgical procedures. These agents achieve their effects through modulation of several types of ion channels and neurotransmitter receptors in the central nervous system—most notably potentiation of inhibitory GABAergic transmission via GABA_A receptors, inhibition at excitatory glutamatergic NMDA receptors, activation/modulation at certain potassium channels, among others. There is no universal “anesthetic receptor”; each drug may preferentially interact with different proteins depending on its chemical structure and pharmacology. Thus, listing “Anesthetic” as an individual therapeutic target is scientifically inaccurate—it should be replaced with more precise terms such as “GABA_A receptor,” “NMDA receptor,” etc., when referring to mechanisms relevant for specific drugs within this class.

Other names

General anestheticLocal anestheticAnesthesia agent

General anesthetics work primarily by: Potentiating inhibitory neurotransmission via GABA_A receptors (increasing chloride influx and hyperpolarizing neurons); Inhibiting excitatory neurotransmission via NMDA receptors and other ion channels; Modulating potassium channels to hyperpolarize neurons and reduce neuronal activity. No single mechanism applies universally; each agent may have distinct primary actions.